Gene therapy and tissue engineering for sports medicine
- 20 November 2002
- journal article
- review article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 5 (2) , 93-108
- https://doi.org/10.1002/jgm.344
Abstract
Sports injuries usually involve tissues that display a limited capacity for healing. The treatment of sports injuries has improved over the past 10 to 20 years through sophisticated rehabilitation programs, novel operative techniques, and advances in the field of biomechanical research. Despite this considerable progress, no optimal solution has been found for treatment of various sports‐related injuries, including muscle injuries, ligament and tendon ruptures, central meniscal tears, cartilage lesions, and delayed bone fracture healing. New biological approaches focus on the treatment of these injuries with growth factors to stimulate and hasten the healing process. Gene therapy using the transfer of defined genes encoding therapeutic proteins represents a promising way to efficiently deliver suitable growth factors into the injured tissue. Tissue engineering, which may eventually be combined with gene therapy, may potentially result in the creation of tissues or scaffolds for regeneration of tissue defects following trauma. In this article we will discuss why gene therapy and tissue engineering are becoming increasingly important in modern orthopaedic sports medicine practice. We then will review recent research achievements in the area of gene therapy and tissue engineering for sports‐related injuries, and highlight the potential clinical applications of this technology in the treatment of patients with musculoskeletal problems following sports‐related injuries. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 201 references indexed in Scilit:
- Synergistic enhancement of bone formation and healing by stem cell–expressed VEGF and bone morphogenetic protein-4Journal of Clinical Investigation, 2002
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001
- Gene Therapy-Directed Osteogenesis: BMP-7-Transduced Human Fibroblasts Form Bonein VivoHuman Gene Therapy, 2000
- Osteoinduction by Bone Morphogenetic Protein-2 via Adenoviral Vector under Transient ImmunosuppressionBiochemical and Biophysical Research Communications, 2000
- Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cellsJournal of Orthopaedic Research, 1998
- Adenovirus‐mediated gene transfer into tendon and tendon sheathJournal of Orthopaedic Research, 1996
- Regional mitogenic response of the meniscus to platelet‐derived growth factor (PDGF‐AB)Journal of Orthopaedic Research, 1995
- Suramin inhibits growth and transforming growth factor-β1 (TGF-β1) binding in osteosarcoma cell linesEuropean Journal Of Cancer, 1994
- Fibroblast growth factor, epidermal growth factor, insulin‐like growth factors, and platelet‐derived growth factor‐BB stimulate proliferation of clonally derived porcine myogenic satellite cellsJournal of Cellular Physiology, 1993
- Expression of PDGF A-chain and beta-receptor genes during rat myoblast differentiation.The Journal of cell biology, 1990